Use of mitomycin C in the pediatric airway

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 6, 2004, Pages 473-475

  Senders, Craig W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Choanal atresia; Granulation tissue; Mitomycin; Subglottic stenosis; Tracheal stenosis

Indexed keywords

MITOMYCIN C;

ATROPHY; BRONCHUS STENOSIS; CHOANA ATRESIA; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG USE; ESOPHAGUS STENOSIS; GRANULATION TISSUE; HUMAN; MEDICAL SPECIALIST; MUCOUS MEMBRANE PEMPHIGOID; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SHORT SURVEY; SUBGLOTTIC STENOSIS; TRACHEA STENOSIS; WOUND HEALING;

ANIMALS; CHILD; GRANULATION TISSUE; HUMANS; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; POSTOPERATIVE COMPLICATIONS; RECONSTRUCTIVE SURGICAL PROCEDURES; RESPIRATORY SYSTEM; TRACHEAL STENOSIS; WOUND HEALING;

EID: 9444255116     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000146708.64004.2b     Document Type: Short Survey

References (22)

1. Hata T, Sano Y, Sugawara R, et al.: Mitomycin, a new antibiotic from Streptomyces. Int J Antibiot 1956, 9:141-146.
2. Micromedex MICROMEDEX: ® Healthcare Series Vol. 108 (www.mdx.com)
3. Tomsaz M, Palom Y: The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activity. Pharmacol Then 1997, 76:73-87.
4. Cummings J, Spanswick VJ, Tomasz, et al.: Enzymology of mitomycin-C metabolic activiation in tumor tissue: implications for enzyme-directed bioreductive drug development. Biochem Pharmacol 1998, 56:405-414.
5. Singh G, Wilson MR, Foster CS: Mitomycin eye drops as treatment for pterygium. Ophthalmology 1997, 95:813-821.
6. Kitazawa Y, Suemori-Matsushita H, Yamamoto T, et al.: Low dose and high dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 1993, 100:1624-1628.
7. Megevand GS, Salmon JF, Scholtz RP, et al.: The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 1995, 102:84-90.
8. Ward RF, April MM: Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction. Int J Pediatr Otorhinolaryngol 1998, 44:221-226.
9. Rahbar R, Valdez TA, Shapshay SM: Preliminary results of infra-operative mitomycin-C in the treatment and prevention of glottic and subglottic. J Voice 2000, 14:282-286.
10. Rahbar R, Shapshay SM, Healy GB: Mitomycin: effects on laryngeal and tracheal stenosis: benefits and complications. Ann Otol Rhinol Laryngol 2001, 110:1-6.
11. Unal M: The successful management of congenital laryngeal web with endoscopic lysis and topical mitomycin-C. Int J Pediatr Otorhinolaryngol 2004, 68:231-235. A case report of treating a laryngeal web with 1 mg/mL mitomycin C topically with a favorable result.
12. Rahbar R, Jones DT, Nuss RC, et al.: The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract. Arch Otolaryngol Head Neck Surg 2002, 128:401-406.
13. Kao SCS, Liao CL: Dacryocystorhinostomy with intraoperative mitomycin. Ophthalmology 1997, 104:86-91.
14. Hartnick CJ, Hartley BEJ, Lacy PD, et al.: Topical mitomycin application after laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg 2001, 127:1260-1264.
15. Hardillo J, Vanclooster C, Delaere PR: An investigation of airway wound healing using a novel in vivo model. Laryngoscope 2003, 113:237-242. This is a complex multisurgical stage animal model that was used to study the effects of mitomycin C.
16. Correa AJ, Reinish L, Sanders DL, et al.: Inhibition of subglottic stenosis with mitomycin-C in the canine model. Ann Otol Rhinol Laryngol 1999, 108:1053-1060.
17. Spector JE, Werkhaven JA, Spector NC, et al.: Preservation of function and histologic appearance in the injured glottis with topical mitomycin-C. Laryngoscope 1999, 109:1125-1129. hearing in a canine model. Ann Otol Rhinol Laryngol 2001, 110:15-30.
18. Spector JE, Werkhaven JA, Spector NC, et al.: Preservation of function and histologic appearance in the injured glottis with topical mitomycin-C. Laryngoscope 1999, 109:1125-1129. hearing in a canine model. Ann Otol Rhinol Laryngol 2001, 110:15-30.
19. Cable BB, Pazos GA, Brietzke SE, et al.: Topical mitomycin therapy in the pediatric airway: state of the art. Pediatric Oto Service, Walter Reed Army Medical Center. An excellent review and presentation of a case series, all with favorable results. The authors use 10 mg/mL mitomycin C topically.
20. Ingrams DR, Volk MS, Biesman BS, et al.: Sinus surgery: does mitomycin C reduce stenosis? Am Laryngol Rhinol Otol Soc 1998, 108:883-886.
21. Gray SD, Tritle N, Li W: The effect of mitomycin on extracellular matrix proteins in a rat wound model. Laryngoscope 2003, 113:237-242. A rat animal study of the expression of RNA for proteins seen in wound healing.
22. Eliashar R, Eliachar I, Esclamado R, et al.: Can topical mitomycin prevent laryngotracheal stenosis. Invest Ophthalmol 1994, 35:3789-3891.